Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition.

Kim S, Lee H, Moon H, Kim R, Kim M, Jeong S, Kim H, Kim SH, Hwang SS, Lee MY, Kim J, Song BW, Chang W.

Open source

DOI: 10.3390/antiox12051059
Published: 2023-05-07
Container: Antioxidants (Basel)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/antiox12051059,
  title = {Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition.},
  author = {Kim S and  Lee H and  Moon H and  Kim R and  Kim M and  Jeong S and  Kim H and  Kim SH and  Hwang SS and  Lee MY and  Kim J and  Song BW and  Chang W.},
  year = {2023},
  journal = {Antioxidants (Basel)},
  doi = {10.3390/antiox12051059},
  url = {https://doi.org/10.3390/antiox12051059}
}

RIS

TY  - JOUR
TI  - Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition.
AU  - Kim S
AU  -  Lee H
AU  -  Moon H
AU  -  Kim R
AU  -  Kim M
AU  -  Jeong S
AU  -  Kim H
AU  -  Kim SH
AU  -  Hwang SS
AU  -  Lee MY
AU  -  Kim J
AU  -  Song BW
AU  -  Chang W.
PY  - 2023
JO  - Antioxidants (Basel)
DO  - 10.3390/antiox12051059
UR  - https://doi.org/10.3390/antiox12051059
ER  -

APA

S, K., H, L., H, M., R, K., M, K., S, J., H, K., SH, K., SS, H., MY, L., J, K., BW, S., & W., C. (2023). Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition.. Antioxidants (Basel). https://doi.org/10.3390/antiox12051059

Source records

europe-pmc · retrieved 2026-09-27T00:07:42.732Z
doaj · retrieved 2026-09-27T00:07:42.736Z